Rankings
▼
Calendar
STAA Q4 2023 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena
STAA
STAAR Surgical Company
$860M
Q4 2023 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$76M
+19.1% YoY
Gross Profit
$61M
79.6% margin
Operating Income
$10M
13.6% margin
Net Income
$8M
10.2% margin
EPS (Diluted)
$0.16
QoQ Revenue Growth
-5.0%
Cash Flow
Operating Cash Flow
$32M
Free Cash Flow
$29M
Stock-Based Comp.
$182,000
Balance Sheet
Total Assets
$489M
Total Liabilities
$103M
Stockholders' Equity
$386M
Cash & Equivalents
$183M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$76M
$64M
+19.1%
Gross Profit
$61M
$50M
+22.0%
Operating Income
$10M
$964,000
+979.4%
Net Income
$8M
$6M
+32.5%
Revenue Segments
Implantable Collamer Lenses
$75M
98%
Other Surgical Products
$2M
2%
← FY 2023
All Quarters
Q1 2024 →